AEMD Aethlon Medical, Inc.

6.070USD-0.33%Mkt Cap: 9.74M $P/E: —

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address un…

Key Statistics

Company
Market Cap9.74M USD
Enterprise Value-235.15K USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-7.15M USD
Revenue/Share—
Last Price6.070 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees9
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.68
PEG—
EV/EBITDA0.04
EV/Revenue—
P/S—
P/B0.56
EPS (TTM)-30.85
EPS (Forward)-0.57
52W Range
1.41012% of range41.50
52W High41.50 USD
52W Low1.410 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-146.36%
ROA-112.92%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.00M USD
CapEx (TTM)3.70K USD
FCF Margin—
FCF Yield-49.22%
Net Debt-4.57M USD
Net Debt/EBITDA0.67
Balance Sheet
Debt/Equity0.07
Current Ratio5.42
Quick Ratio4.76
Book Value/Sh10.89 USD
Cash/Share6.94 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 15, 2019
Splits
Last Split1:5
Split DateAug 4, 2026
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)13.25 USD
Upside (mean)+118.3%
Target Range1.500 USD – 25.00 USD
1.500+118.3% to mean25.00
# Analysts2
Ownership
Shares Out.1.60M
Float702.05K
Insiders0.58%
Institutions4.34%
Short Interest
Short Ratio0.0d
Short % Float4.67%
Short % Out.4.67%
Shares Short74.85K
Short (prev mo.)65.08K
Technical
SMA 503.606 (+68.3%)
SMA 2008.485 (-28.5%)
Beta1.21
S&P 52W Chg16.45%
Avg Vol (30d)1.73M
Avg Vol (10d)117.81K
Technical Indicators
RSI (14)64.6
MACD0.8911
MACD Signal0.8544
MACD Hist.+0.0366
BB Upper9.549 USD
BB Middle4.985 USD
BB Lower0.4213 USD
BB Width183.10%
ATR (14)0.5088 USD
Vol Ratio (20d)0.10x